Implementing an optimized glucose-lowering strategy with a novel once daily modified release gliclazide formulation


Leiter L. A. , Shestakova M. V. , Trubitsyna N. P. , Piletic M., Satman I.

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.112, ss.50-56, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 112
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.diabres.2015.11.001
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Sayfa Sayıları: ss.50-56

Özet

Aim: The 6-months titration profile of a new scored gliclazide modified release (MR) formulation (MR 60 mg) was explored in individuals with type 2 diabetes.